Gastric
& Breast Cancer e-journal
DOI:
10.2122/gbc.2007.0057
COMMENTARY
|
Prevention of hereditary cancer syndromes
|
Dimosthenis Ziogas, M.D. and Charalampos Batsis, M.D. |
| |
Breast, colorectal and gastric cancers affect approximately 3 million people and kill over 1,6 million patients each year worldwide [1]. Primary prevention is obviously the most promising research strategy to save the lives of these patients. Although Effective chemoprevention drugs have been developed as tamoxifen for the prevention of women with a moderate or high risk of breast cancer [2] and aspirin or COX-2 inhibitors for the prevention of colorectal cancer [3 they are not in wide clinical use because if their adverse effects in health individuals and for various other reasons [2,3]
|
|
|
|
Find Delta Dental, MetLife Dental, Aetna Dentist, New York Dentist, San Francisco Dentist, Boston Dentist, Chicago Dentist, Los Angeles Dentist & San Diego Dentist at DoctorsImprovingHealthcare.org. Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 3 February 2004 |
|
|
|
